Mizuho Securities Downgrades ResMed (RMD) to Neutral
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $224.46 -1.01%
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Rating Summary:
11 Buy, 12 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 9
Join SI Premium – FREE
Mizuho Securities downgraded ResMed (NYSE: RMD) from Outperform to Neutral. PT lowered from $38 to $32.
For more ratings news on ResMed click here and for the rating history of ResMed click here.
Shares of ResMed closed at $33.61 yesterday.
For more ratings news on ResMed click here and for the rating history of ResMed click here.
Shares of ResMed closed at $33.61 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keefe, Bruyette & Woods Downgrades Bain Capital Specialty Finance (BCSF) to Market Perform
- Raymond James Downgrades Accelerant Holdings (ARX) to Market Perform
- JPMorgan Downgrades KinderCare Learning Companies (KLC) to Underweight
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
